Barriers to Breast Cancer-Screening in Vulnerable Populations
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
6-Jun-2023 1:15 PM EDT
Add to Favorites
Therapy Animals and a Review of the Risk for Zoonotic Transmission
Animal-Assisted interventions (AAI) are implemented in hospitals and rehabilitation centers to produce many advantages for the patients but could expose them to pathogens transmission, a process known as zoonosis.
22-May-2023 8:00 AM EDT
Add to Favorites
Researchers Target Commonly Mutated or Deleted Gene in Gynecological Cancers
A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers.
18-May-2023 8:25 AM EDT
Add to Favorites
Antonio Giordano, M.D., Ph.D. Honored with da Vinci Award by the Italian Heritage and Culture Committee of New York
Members of the Board of Directors of the Italian Heritage and Culture Committee-NY, Inc. (IHCC-NY) honored Dr. Antonio Giordano, Founder and Director of the Sbarro Health Research Organization (SHRO) on April 24, 2023, with its coveted Leonardo da...
27-Apr-2023 11:35 AM EDT
Add to Favorites
New Review Reveals the Critical Role of Progranulin in Cancer
A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in the initiation and progression of cancer.
30-Mar-2023 4:15 PM EDT
Add to Favorites
Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO
The Sbarro Health Research Organization (SHRO), led by Prof. Antonio Giordano, in collaboration with the Texas Scientific Italian Community (TSIC), led by Prof. Andrea Giuffrida, will present the XVII Conference of Italian Researchers in the World...
29-Mar-2023 3:30 PM EDT
Add to Favorites
SHRO's Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine
Artificial Intelligence and NGS Integrated into the Next Generation Tissue Microarrays (TMA) Workshop
6-Mar-2023 6:05 PM EST
Add to Favorites
Cancer: In Italy every year over 8000 patients candidate for liquid biopsy
SHRO Founder Antonio Giordano contributes to a new publication on the use of liquid biopsy to assess the treatment response and find mutations that confer resistance to cancer therapies.
21-Feb-2023 10:10 PM EST
Add to Favorites
See All News
Using Virtual Reality for Patient Support, SHRO’s Giordano Discusses
20-Sep-2022 8:05 AM EDT
"We've got to get our act together" on public health measures to combat COVID, says Fauci
3-Nov-2020 2:35 PM EST
‘Genetic Shield’ May Explain Lower COVID Mortality in Southern Italy Compared to North
4-Jun-2020 9:55 AM EDT
Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST
Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert
16-Jan-2018 11:05 AM EST
Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST
Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.
RSS